Mr. Toy and Mr. Smith own stock or stock options in Amgen, Inc.
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis
Version of Record online: 26 FEB 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 60, Issue 3, pages 738–749, March 2009
How to Cite
Palmer, G., Talabot-Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E. and Gabay, C. (2009), Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis & Rheumatism, 60: 738–749. doi: 10.1002/art.24305
- Issue online: 26 FEB 2009
- Version of Record online: 26 FEB 2009
- Manuscript Accepted: 7 NOV 2008
- Manuscript Received: 24 APR 2008
- de Reuter Foundation
- Swiss National Science Foundation. Grant Number: 3200-107592/1
Additional Supporting Information may be found in the online version of this article.
|ART_24305_sm_SupplTable1.doc||15K||Supplementary table 1. Transcript expression profiling|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.